List of Acanya drug patents

Acanya is owned by Bausch.

Acanya contains Benzoyl Peroxide; Clindamycin Phosphate.

Acanya has a total of 9 drug patents out of which 0 drug patents have expired.

Acanya was authorised for market use on 23 October, 2008.

Acanya is available in gel;topical dosage forms.

Acanya can be used as topical treatment of acne vulgaris; treatment of acne; treatment of acne vulgaris; topical treatment of acne vulgaris; treatment of acne vulgaris; topical treatment of acne vulgaris in patients 12 years or older, topical treatment of acne vulgaris in patients 12 years or older, treatment of acne, treatment of acne vulgaris; topical treatment of acne vulgaris; topical treatment of acne vulgaris in patients 12 years or older; treatment of acne.

The generics of Acanya are possible to be released after 05 August, 2029.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9078870 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(6 years from now)

US9561208 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(6 years from now)

US10220049 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(6 years from now)

US9504704 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(6 years from now)

US8895070 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(6 years from now)

US10137142 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(6 years from now)

US10624918 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(6 years from now)

US8663699 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(6 years from now)

US8288434 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Aug, 2029

(6 years from now)

Drugs and Companies using BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE ingredient

Market Authorisation Date: 23 October, 2008

Treatment: Topical treatment of acne vulgaris in patients 12 years or older; Treatment of acne vulgaris; Topical treatment of acne vulgaris; Treatment of acne

Dosage: GEL;TOPICAL

How can I launch a generic of ACANYA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in